openPR Logo
Press release

Myopia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and companies by DelveInsight | Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics

06-14-2024 06:26 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Myopia Pipeline

Myopia Pipeline

(Albany, USA) As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 10+ pipeline drugs in the Myopia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Myopia Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Myopia Therapeutics Market.
The report provides a detailed description of the Myopia drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Myopia Clinical Trial Activities and Regulatory Developments in the domain @ https://www.delveinsight.com/report-store/myopia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Myopia Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Myopia therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Myopia treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Myopia drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Myopia treatment market.

Learn More about the Clinical and Commercial Development Activities in the Myopia Therapeutics Domain @ https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Myopia Therapeutics Analysis
Around 8+ prominent companies are actively engaged in the development of therapies for Myopia. Among these, Sydnexis stands out for advancing its Myopia drug candidates to the most advanced stage of clinical trials, specifically Phase III. This pivotal phase marks a critical milestone in the drug development journey, where the effectiveness and safety of the treatment are thoroughly evaluated in a larger patient population. Sydnexis's progress to Phase III underscores the potential significance of their therapeutic approach in addressing the challenges associated with Myopia, reflecting dedication and advancement within the field of ophthalmology and vision care.

Myopia Companies in the Therapeutics Market Include:
• Sydnexis
• Sunhawk Vision Biotech
• Vyluma
• Eyenovia
• Cloudbreak Therapeutics
• Stuart Therapeutics
And Many Others

Emerging and Marketed Myopia Therapies Covered in the Report Include:
• SYD-101: Sydnexis
• MicroPine: Eyenovia
And Many Others

Get an in-depth Assessment of the Emerging Therapies and Myopia Companies Actively Working in the Market @ https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

The Report Covers the Emerging Myopia Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Myopia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal

Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule

Request for Sample PDF to Understand More About the Myopia Treatment Outlook and Future Perspectives @ https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content
1. Report Introduction
2. Executive Summary
3. Myopia Current Treatment Patterns
4. Myopia - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Myopia Late-Stage Products (Phase-III)
7. Myopia Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Myopia Discontinued Products
13. Myopia Product Profiles
14. Myopia Companies
15. Myopia Drugs
16. Dormant and Discontinued Products
17. Myopia Unmet Needs
18. Myopia Future Perspectives
19. Myopia Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @ https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports:
• Biochips Market: https://www.delveinsight.com/report-store/biochips-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Pain Management Devices Market: https://www.delveinsight.com/report-store/pain-management-devices-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Vascular Access Devices Market: https://www.delveinsight.com/report-store/vascular-access-device-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Lymphocytopenia Market: https://www.delveinsight.com/report-store/lymphocytopenia-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Bradycardia Treatment Devices Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-epidemiology-forecast
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Bartonellosis Market: https://www.delveinsight.com/report-store/bartonellosis-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market
• Ocular Motility Disturbance Market: https://www.delveinsight.com/report-store/ocular-motility-disturbance-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/asco-conference-coverage

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myopia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and companies by DelveInsight | Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics here

News-ID: 3538646 • Views:

More Releases from DelveInsight Business Research

Migraine Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Eli Lilly and Company, Teva Pharmaceuticals, Axsome Therapeutics, AEON Biopharma, Inc., Charleston Laboratories, Amgen, Teva Pharmaceuticals, Eli Lilly and Company, Anne Lindb
Migraine Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | …
The Migraine market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Migraine pipeline products will significantly revolutionize the Migraine market dynamics. DelveInsight's "Migraine Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Migraine, historical and forecasted epidemiology as well as the Migraine market trends in the United States, EU4 (Germany, Spain, Italy, France)
Radiodermatitis Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Apeiron Biologics, Lutris Pharma Ltd., Reata Pharma, Lutris Pharma, Enveric Biosciences
Radiodermatitis Market Growth to Accelerate in Forecast Period (2023-2032), Delv …
DelveInsight's "Radiodermatitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Radiodermatitis, historical and forecasted epidemiology as well as the Radiodermatitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Radiodermatitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Radiodermatitis Market Forecast https://www.delveinsight.com/sample-request/radiodermatitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key facts of the Radiodermatitis
Chronic Pain Associated With Painful Diabetic Neuropathy Market on Track for Major Expansion by 2032, According to DelveInsight | AstraZeneca, Regenacy Pharmaceuticals, Nevro Corp., Erchonia Corporation
Chronic Pain Associated With Painful Diabetic Neuropathy Market on Track for Maj …
DelveInsight's "Chronic Pain Associated With Painful Diabetic Neuropathy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Pain Associated With Painful Diabetic Neuropathy, historical and forecasted epidemiology as well as the Chronic Pain Associated With Painful Diabetic Neuropathy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Chronic Pain Associated With Painful
Chronic Pain Market to Expand Significantly by 2032, States DelveInsight Report | Paradigm Biopharmaceuticals, Noven Pharmaceuticals, GSK, Sustained Therapeutics Inc., Apurano Pharmaceuticals GmbH, Carolinas Pain Institute Beijing Konruns Pharmaceutical
Chronic Pain Market to Expand Significantly by 2032, States DelveInsight Report …
DelveInsight's "Chronic Pain Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Chronic Pain, historical and forecasted epidemiology as well as the Chronic Pain market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Chronic Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Pain Market Forecast https://www.delveinsight.com/sample-request/chronic-lower-back-pain-clbp-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the

All 5 Releases


More Releases for Myopia

Adult Myopia Market Register to Healthy Growth through 2027
Adult myopia development is a common occurrence in practise, although there is little data to assist care. In this article, we'll look at how often and how much myopia progresses in adults, as well as treatment choices. We have some study data accessible on myopic teens and the stabilisation of their myopia development. Myopia stability and related variables among COMET trial participants, as well as the effects of discontinuing orthokeratology
Myopia Management System Market Size | COVID-19 Impact Analysis | Forecast to 20 …
Myopia Management System market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. (Get 15% Discount on Buying this Report) A full report of Global Myopia Management System Market is available at: https://www.orionmarketreports.com/myopia-management-system-market/49566/ The Myopia Management System key players in this market include: • Zeiss International • Essilor • Bausch & Lomb • Johnson & Johnson Vision • Alcon Vision • Topcon Corporation • Haag-Streit
Global Myopia Control Contact Lenses Market with Coronavirus (COVID-19) Impact A …
 The research study presented here is an intelligent take on the global Myopia Control Contact Lenses market that explains important aspects such as competition, segmentation, and regional growth in great detail. Accuracy and preciseness are two of the key features of the report that reflect its authenticity. The authors of the report have focused on SWOT analysis, Porter’s Five Forces analysis, and PESTLE analysis of the global Myopia Control Contact Lenses market.
Myopia Control Lens (Plastic Lens) Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Myopia Control Lens (Plastic Lens) market analysis, which studies the Myopia Control Lens (Plastic Lens)'s industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Myopia Control Lens (Plastic Lens) Market 2020-2025” Research Report categorizes the global Myopia Control Lens (Plastic Lens) market by key players, product type, applications and regions,etc. The report
Orthokeratology Market: Ortho-K May Gain Excellent Traction among Young Myopia P …
Orthokeratology has been considered to facilitate the elimination of contact lens related vision problems, providing patients with the freedom to experience an active lifestyle. While this factor will continue to play a pivotal role in growing adoption of Ortho-K lenses, Future Market Insights has discovered a few other factors that are likely to impact the growth of orthokeratology market in near future. In a recently released report, titled “Orthokeratology Market: Global Industry
Orthokeratology (Ortho-K) Market Demand Getting High Rise Due to Increasing Prev …
Orthokeratology (Ortho-K) is a non-surgical procedure using specially designed contact lenses to gently reshape the curvature of the eye to improve vision. It is most frequently used to temporarily correct myopia (near-sightedness). Ortho-k can correct upwards of -6.00 diopters (D) of myopia. It is also useful in correction of lesser degrees of astigmatism, presbyopia and hyperopia. Overnight ortho-K lenses are most commonly used in comparison to daytime wear. According to